Welcome to our dedicated page for Coca-Cola Europacific Partners Plc SEC filings (Ticker: CCEP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Coca-Cola Europacific Partners plc (CCEP) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, primarily filed on Form 20-F and Form 6-K as a foreign private issuer. These documents cover a wide range of information, from annual reports and audited financial statements to interim trading updates, capital markets announcements, share buyback activity and governance changes.
In its Form 20-F annual report and related filings, CCEP presents detailed financial statements and notes for the year, including revenue, volume in unit cases, revenue per unit case, operating profit and comparable free cash flow. Investors can also review discussions of alternative performance measures such as comparable and adjusted comparable results, and FX-neutral metrics, which CCEP uses to illustrate underlying trends across its European and APS segments.
Frequent Form 6-K submissions include quarterly trading updates, interim dividend declarations, and lists of public announcements required under the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. Many of these 6-Ks reproduce the same trading tables and commentary found in CCEP’s market releases, providing SEC-registered access to information on category performance, channel trends, guidance for revenue and operating profit growth, and capital expenditure plans.
Other 6-K filings document transactions in CCEP’s own shares under its share buyback programme, specifying daily repurchase volumes and prices across US and UK trading venues, with repurchased shares to be cancelled. Governance-related filings report Board succession planning and director appointments, as well as notifications of total voting rights and PDMR share dealings.
On Stock Titan, AI-powered tools can help summarise lengthy CCEP filings, highlight key figures and definitions, and surface items such as dividend payout ratios, share repurchase authorisations and index-related disclosures. Real-time ingestion from EDGAR means new CCEP 6-Ks and 20-Fs appear promptly, while structured views of Form 6-K content make it easier to track recurring elements like trading updates, guidance revisions and buyback progress.
Coca-Cola Europacific Partners plc reports a series of December 2025 transactions in its own ordinary shares under its previously announced share buyback programme. On dates including 9 December 2025 and 15 December 2025, the company repurchased ordinary shares on US Trading Venues and, on most days, on London Trading Venues, such as 36,817 shares on US venues and 24,449 shares on London venues on 9 December 2025, and 37,600 shares on US venues on 15 December 2025. The repurchased ordinary shares will be cancelled.
These purchases form part of the Programme announced on 14 February 2025, under which the company expects to repurchase up to EUR 1 billion of ordinary shares in aggregate. For the final tranche of the Programme, the aggregate amount of purchases is stated as EUR 382,000,000, and the company notes that the amount in respect of the US Trading Venues has been increased from EUR 280,000,000 to EUR 280,394,000 while the overall tranche size remains the same, with purchases on US venues expected to be completed by 19 December 2025.
Coca-Cola Europacific Partners plc (CCEP) has filed a Form 6-K summarising routine share repurchases under its previously announced buyback programme.
The company reports daily purchases of its own ordinary shares between 18 and 24 November 2025 on US trading venues, with additional London market purchases on 24 November 2025, including 36,600 shares on US venues and 24,645 shares across London venues that day. All repurchased shares will be cancelled, reducing the share count over time.
These transactions are part of a wider programme announced on 14 February 2025, under which CCEP expects to repurchase up to EUR 1 billion of ordinary shares in aggregate. The filing notes that the announcements are informational and do not constitute an offer or solicitation to buy or sell securities.
Coca-Cola Europacific Partners plc (CCEP) provides an update on shareholder voting at its 2025 Annual General Meeting, focusing on the Rule 9 waiver linked to its share buyback authority. All resolutions at the AGM were passed, but the Rule 9 Waiver Resolution received lower support, with 74.95% of votes cast in favour, compared with very high approval for related buyback authorities in resolutions 27 and 28, at 99.22% and 98.22% respectively.
The Rule 9 waiver allows CCEP to continue repurchasing its own shares without triggering a mandatory takeover offer by Olive Partners, S.A. if its ownership percentage rises due to buybacks. The Board links this to its previously announced commitment to return up to €1bn to shareholders via share buybacks and states that buybacks are a core element of its capital allocation framework. The Board acknowledges shareholder concerns about Rule 9 waivers, notes ongoing engagement with investors, and says it continues to consider alternative ways of returning capital.
Coca-Cola Europacific Partners plc (CCEP) reports a series of share repurchases in November 2025 under its share buyback programme of up to EUR 1 billion of ordinary shares. The company states that all repurchased shares will be cancelled.
On 11 November 2025, CCEP purchased 71,676 ordinary shares on US trading venues at prices between USD 91.9900 and USD 93.3600 per share, and 34,000 ordinary shares on London trading venues. On 12 November 2025, it bought 69,878 ordinary shares on US trading venues and 34,000 on London venues, followed by 70,701 and 20,000 ordinary shares respectively on 13 November 2025.
Further purchases included 72,285 ordinary shares on US trading venues and 15,350 on London venues on 14 November 2025, and 72,183 ordinary shares on US trading venues on 17 November 2025. The repurchases took place across Nasdaq and other US venues, as well as the London Stock Exchange, CBOE Europe and Aquis.
Coca-Cola Europacific Partners (CCEP) filed a Form 6-K reporting daily share repurchases carried out between 4 and 10 November 2025 under its buyback programme, under which the company expects to repurchase up to EUR 1 billion of ordinary shares. All repurchased shares will be cancelled. Purchases were executed on US Trading Venues (including Nasdaq) via Jefferies LLC and on London Trading Venues via Jefferies International Limited.
Disclosed daily activity: on 4 Nov, 75,415 shares on US venues and 34,000 on London venues; on 5 Nov, 74,660 (US) and 34,000 (London); on 6 Nov, 73,944 (US) and 34,000 (London); on 7 Nov, 73,606 (US) and 33,958 (London); on 10 Nov, 71,388 (US) and 32,000 (London). The disclosures include venue-level highest, lowest and volume‑weighted average prices for each day.
Coca-Cola Europacific Partners filed a Form 6-K with a Q3 trading update and an interim dividend declaration. Reported revenue was €5,410m in Q3, up 1.0%, with adjusted comparable FXN revenue up 3.2%. Year-to-date reported revenue reached €15,684m (up 3.3%), and adjusted comparable FXN revenue grew 2.7%.
Q3 adjusted comparable volume increased 0.4% and revenue per unit case rose 2.7%. Europe delivered €4,194m of Q3 revenue with adjusted comparable revenue per unit case up 3.4%, while APS posted €1,216m with FXN revenue down 0.2%. Management noted slightly lower transactions than volume due to weather in the Philippines and softer consumer sentiment in Europe.
The Board declared a second-half interim dividend of €1.25 per share, payable on 3 December 2025 to shareholders of record on 14 November 2025, resulting in a full-year dividend of €2.04 per share and maintaining an approximately 50% dividend payout ratio. Jefferies International Limited was appointed joint corporate broker alongside BNP Paribas and Deutsche Bank.
Coca-Cola Europacific Partners (CCEP) reported a solid third quarter and reaffirmed full‑year guidance. Q3 reported revenue was €5,410m (up 1.0%), with adjusted comparable FX‑neutral revenue up 3.2%. Adjusted comparable volume rose 0.4%, and revenue per unit case increased 2.7%. Europe volume grew 0.9% while APS declined 0.6%. Year‑to‑date reported revenue reached €15,684m (up 3.3%), with adjusted comparable FX‑neutral revenue up 2.7%.
CCEP declared a second‑half interim dividend of €1.25 per share, payable on 3 December 2025 to shareholders of record on 14 November 2025, resulting in a full‑year dividend per share of €2.04 and maintaining an approximately 50% payout ratio. Management reaffirmed FY25 outlook: revenue growth of 3%–4% (adjusted comparable, FX‑neutral), cost of sales per unit case growth of about 2.5%, operating profit growth of about 7%, comparable effective tax rate around 26%, capex near 5% of revenue, and comparable free cash flow of at least €1.7bn. The €1bn share buyback is to be completed during calendar 2025, with about €809m completed to date. CCEP noted an expected full‑year FX headwind of ~180 bps to revenue and ~200 bps to operating profit.
Coca-Cola Europacific Partners (CCEP) furnished a 6-K detailing recent share repurchases under its buyback programme. The company repurchased ordinary shares on multiple trading days between 28 October and 3 November 2025 across US and London venues, and stated that all repurchased shares will be cancelled. The purchases form part of the Programme announced on 14 February 2025, under which CCEP expects to repurchase up to EUR 1 billion of ordinary shares in aggregate.
Examples from the period include 71,865 shares on US venues and 34,000 on London venues on 28 October, and 73,242 on US venues and 34,000 on London venues on 3 November. Transactions were executed by Jefferies LLC (US) and Jefferies International Limited (London), with disclosures made in line with the Market Abuse Regulation. The company reiterated that these transactions do not constitute an offer or solicitation for securities.
Coca-Cola Europacific Partners (CCEP) furnished a 6-K summarizing October disclosures under the FCA’s DTR rules. The company issued a correction on October 10 to its prior notice and confirmed the figures for September month-end. As at 30 September 2025, CCEP had 453,908,343 ordinary shares in issue, each with one vote, and no shares in treasury.
CCEP also reported routine PDMR dealings. Transactions included small share acquisitions through the Employee Share Purchase Plan and UK Share Plan, and limited sales solely to fund tax liabilities, with disclosed trade prices such as USD $91.450000 on October 27.
As at 31 October 2025, CCEP had 451,672,150 ordinary shares in issue, each with one vote, and no shares in treasury. These totals provide the denominator for notification thresholds under the FCA’s Disclosure Guidance and Transparency Rules.
Coca-Cola Europacific Partners (CCEP) filed a Form 6-K detailing daily transactions in its own shares under its buyback programme. Between October 21–27, 2025, CCEP repurchased ordinary shares on U.S. trading venues each day: 72,112 (Oct 21), 70,994 (Oct 22), 70,903 (Oct 23), 71,116 (Oct 24) and 71,769 (Oct 27). On October 27, it also bought 34,000 shares across London venues (27,400 LSE; 1,000 CXE; 5,500 BXE; 100 Aquis). The repurchased shares will be cancelled.
The purchases form part of the Programme announced on 14 February 2025, under which the Company expects to repurchase up to EUR 1 billion of ordinary shares in aggregate. Reported price metrics included U.S. venue volume-weighted average prices such as USD 91.3525 (Oct 21) and USD 91.4596 (Oct 27), and London venue VWAPs on Oct 27 around GBP 68.66–68.67.